Microbot Medical’s (MBOT) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Microbot Medical (NASDAQ:MBOT – Free Report) in a report issued on Thursday,Benzinga reports. They currently have a $9.00 price target on the biotechnology company’s stock. Microbot Medical Price Performance Shares of NASDAQ MBOT opened at $2.23 on Thursday. The firm’s 50 day simple moving average is […]
